528 related articles for article (PubMed ID: 11139220)
1. Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay.
Lazzarotto T; Galli C; Pulvirenti R; Rescaldani R; Vezzo R; La Gioia A; Martinelli C; La Rocca S; Agresti G; Grillner L; Nordin M; van Ranst M; Combs B; Maine GT; Landini MP
Clin Diagn Lab Immunol; 2001 Jan; 8(1):196-8. PubMed ID: 11139220
[TBL] [Abstract][Full Text] [Related]
2. Improvement of cytomegalovirus avidity testing by adjusting the concentration of CMV-specific IgG in test samples.
Dangel V; Bäder U; Enders G
J Clin Virol; 2006 Mar; 35(3):303-9. PubMed ID: 16298547
[TBL] [Abstract][Full Text] [Related]
3. Improving diagnosis of primary cytomegalovirus infection in pregnant women using immunoblots.
Rajasekariah H; Scott G; Robertson PW; Rawlinson WD
J Med Virol; 2013 Feb; 85(2):315-9. PubMed ID: 23171986
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of CMV seroconversion in a Swiss pregnant women population.
Maine GT; Stricker R; Stricker R
Diagn Microbiol Infect Dis; 2012 Jul; 73(3):275-7. PubMed ID: 22541330
[TBL] [Abstract][Full Text] [Related]
5. Re-evaluation of the VIDAS(®) cytomegalovirus (CMV) IgG avidity assay: determination of new cut-off values based on the study of kinetics of CMV-IgG maturation.
Vauloup-Fellous C; Berth M; Heskia F; Dugua JM; Grangeot-Keros L
J Clin Virol; 2013 Feb; 56(2):118-23. PubMed ID: 23182774
[TBL] [Abstract][Full Text] [Related]
6. Multicenter evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin G avidity.
Baccard-Longere M; Freymuth F; Cointe D; Seigneurin JM; Grangeot-Keros L
Clin Diagn Lab Immunol; 2001 Mar; 8(2):429-31. PubMed ID: 11238233
[TBL] [Abstract][Full Text] [Related]
7. Maternal immunoglobulin G avidity as a diagnostic tool to identify pregnant women at risk of congenital cytomegalovirus infection.
Kaneko M; Ohhashi M; Minematsu T; Muraoka J; Kusumoto K; Sameshima H
J Infect Chemother; 2017 Mar; 23(3):173-176. PubMed ID: 28034524
[TBL] [Abstract][Full Text] [Related]
8. The combination of specific IgM antibodies and IgG antibodies of low avidity does not always indicate primary infection with cytomegalovirus.
Lumley S; Patel M; Griffiths PD
J Med Virol; 2014 May; 86(5):834-7. PubMed ID: 24395084
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays.
Lagrou K; Bodeus M; Van Ranst M; Goubau P
J Clin Microbiol; 2009 Jun; 47(6):1695-9. PubMed ID: 19339470
[TBL] [Abstract][Full Text] [Related]
10. A serological testing algorithm for the diagnosis of primary CMV infection in pregnant women.
Macé M; Sissoeff L; Rudent A; Grangeot-Keros L
Prenat Diagn; 2004 Nov; 24(11):861-3. PubMed ID: 15565653
[TBL] [Abstract][Full Text] [Related]
11. The role of IgG avidity in diagnosis of cytomegalovirus infection in newborns and infants.
Vilibić-Cavlek T; Ljubin-Sternak S; Vojnović G; Sviben M; Mlinarić-Galinović G
Coll Antropol; 2012 Mar; 36(1):297-300. PubMed ID: 22816235
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the indirect and IgM-capture anti-human cytomegalovirus IgM ELISA methods as confirmed by cytomegalovirus IgG avidity.
Ikuta K; Koshizuka T; Kanno R; Inoue N; Kubo T; Koyano S; Suzutani T
Microbiol Immunol; 2019 May; 63(5):172-178. PubMed ID: 31012489
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of and screening for cytomegalovirus infection in pregnant women.
Munro SC; Hall B; Whybin LR; Leader L; Robertson P; Maine GT; Rawlinson WD
J Clin Microbiol; 2005 Sep; 43(9):4713-8. PubMed ID: 16145132
[TBL] [Abstract][Full Text] [Related]
14. Potential impact of different cytomegalovirus (CMV) IgM assays on an algorithm requiring IgM reactivity as a criterion for measuring CMV IgG avidity.
Prince HE; Lapé-Nixon M; Brenner A; Pitstick N; Couturier MR
Clin Vaccine Immunol; 2014 Jun; 21(6):813-6. PubMed ID: 24671558
[TBL] [Abstract][Full Text] [Related]
15. Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer.
Maine GT; Stricker R; Schuler M; Spesard J; Brojanac S; Iriarte B; Herwig K; Gramins T; Combs B; Wise J; Simmons H; Gram T; Lonze J; Ruzicki D; Byrne B; Clifton JD; Chovan LE; Wachta D; Holas C; Wang D; Wilson T; Tomazic-Allen S; Clements MA; Wright GL; Lazzarotto T; Ripalti A; Landini MP
J Clin Microbiol; 2000 Apr; 38(4):1476-81. PubMed ID: 10747129
[TBL] [Abstract][Full Text] [Related]
16. Validation of an automated immunoglobulin G-only cytomegalovirus (CMV) antibody screening assay and an assessment of the risk of transfusion transmitted CMV from seronegative blood.
Seed CR; Piscitelli LM; Maine GT; Lazzarotto T; Doherty K; Stricker R; Stricker R; Iriarte B; Patel C
Transfusion; 2009 Jan; 49(1):134-45. PubMed ID: 18954407
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays.
Revello MG; Genini E; Gorini G; Klersy C; Piralla A; Gerna G
J Clin Virol; 2010 Aug; 48(4):255-9. PubMed ID: 20561816
[TBL] [Abstract][Full Text] [Related]
18. Serological markers as indicators for congenital cytomegalovirus infection.
Abo-Elwafa HA; Eldin SS; Sharaf AE; Abdelmonem AM
Egypt J Immunol; 2010; 17(2):1-10. PubMed ID: 23082482
[TBL] [Abstract][Full Text] [Related]
19. Prediction of fetal infection in cases with cytomegalovirus immunoglobulin M in the first trimester of pregnancy: a retrospective cohort.
Leruez-Ville M; Sellier Y; Salomon LJ; Stirnemann JJ; Jacquemard F; Ville Y
Clin Infect Dis; 2013 May; 56(10):1428-35. PubMed ID: 23392397
[TBL] [Abstract][Full Text] [Related]
20. Laboratory evaluation of the new Access ® cytomegalovirus immunoglobulin IgM and IgG assays.
Carlier P; Harika N; Bailly R; Vranken G
J Clin Virol; 2010 Nov; 49(3):192-7. PubMed ID: 20801078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
